Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review - Quiz - MDSpire

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review

  • By

  • Vanessa Piechotta

  • Sibylle C. Mellinghoff

  • Caroline Hirsch

  • Alice Brinkmann

  • Claire Iannizzi

  • Nina Kreuzberger

  • Anne Adams

  • Ina Monsef

  • Jannik Stemler

  • Oliver A. Cornely

  • Paul J. Bröckelmann

  • Nicole Skoetz

  • May 31, 2022

  • 0 min

Share

Original Source(s)

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review

  • by Vanessa Piechotta, Sibylle C. Mellinghoff, Caroline Hirsch, Alice Brinkmann, Claire Iannizzi, Nina Kreuzberger, Anne Adams, Ina Monsef, Jannik Stemler, Oliver A. Cornely, Paul J. Bröckelmann, Nicole Skoetz

  • May 31, 2022

Related Content

MIS-C: Diagnosis, Management, and Outcomes

Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib